Late stage broad pipeline: remetinostat, Ph 3 ready topical HDAC inhibitor for early-stage cutaneous T-cell lymphoma; MIV-711, cathepsin K inhibitor for OA, Ph 2 data showed disease modifying effect on knee structure; birinipant, bivalent SMAC mimetic read out positive Ph 1/2 combo (keytruda) data Oct 18: confirmed PR, good safety.
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by